Clinical Trial Update: Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update on semaglutide injection for type 2 diabetes evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Chengdu Brilliant Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: UNKNOWN